RxDoctor Payments Data

Jessica Little, DPM

Foot & Ankle Surgery · Mayfield, KYNPI 1093093254

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (42.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Arthrex at 39.7% of the total. Reporting peaked in 2019 at $3,027 and has fallen 75.1% since, to $753 in 2025.

$7,246in general payments, 2019–2025

Across 115 payments — averaging $63.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3K
  • Gentleman Orthopedic Solutions$3K
  • Treace Medical Concepts, Inc.$336
  • Paratek Pharmaceuticals, Inc.$278
  • Kerecis Limited$169
  • Smith+Nephew$140
  • plus $909 from 21 others

What the payments were for

  • Travel & lodging$1,37419%
  • Food & beverage$2,78138%
  • Education$3,09143%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,246 in reported general payments places this provider in the 70th percentile of 141 foot & ankle surgery providers in Kentucky.

See all foot & ankle surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$175,881
Medicare patients
666
Services billed
4,111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Linezolid21$2,692
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen73$788
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen94$733
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip24$373
Methylprednisolone73$372
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$364
Doxycycline Monohydrate37$345
CeftriaxoneCeftriaxone Sodium16$320
Ondansetron OdtOndansetron13$273
Ciprofloxacin Hcl39$269
Levofloxacin34$239
Ibuprofen37$235
Terbinafine Hcl18$234
Ondansetron Hcl23$191
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim35$130

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Mayfield

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →